Wockhardt Limited
WOCKPHARMA
株式のランク
#4524
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical... Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
株価
$21.04
最終同期: 2026-10-19
時価総額
$3.42B
変化（1日）
-2.39%
変化（1年）
34.90%
国
IN
取引 Wockhardt Limited (WOCKPHARMA)
カテゴリー
Healthcare
Wockhardt Limited（WOCKPHARMA）の発行済株式数
June 2026 時点の発行済株式数 162.49M
Wockhardt Limited の最新の財務報告および株価によると、現在の発行済株式数は 162.49M です。March 2024 の終わりには、同社は 144.25M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Wockhardt Limited（WOCKPHARMA）の発行済株式数の履歴（2004 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 162.49M | 4.41% |
| 2025 | 155.63M | 7.89% |
| 2024 | 144.25M | 0.13% |
| 2023 | 144.06M | 19.50% |
| 2022 | 120.55M | 0.31% |
| 2021 | 120.19M | 0.03% |
| 2020 | 120.15M | 0.05% |
| 2019 | 120.09M | 8.60% |
| 2018 | 110.58M | 0.06% |
| 2017 | 110.51M | -0.60% |
| 2016 | 111.18M | -0.08% |
| 2015 | 111.27M | 0.20% |
| 2014 | 111.04M | -0.15% |
| 2013 | 111.21M | -6.35% |
| 2012 | 118.76M | 0.00% |
| 2011 | 118.76M | 0.00% |
| 2010 | 118.76M | 0.00% |
| 2008 | 118.76M | 0.00% |
| 2007 | 118.76M | 0.02% |
| 2006 | 118.74M | 0.24% |
| 2005 | 118.46M | 0.00% |
| 2004 | 118.46M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 445.06M | 173.90% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 105.38M | -35.15% |
US
|
